D
SELLAS Life Sciences Group, Inc. SLS
$1.92 $0.0955.22% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -26.26M -27.13M -30.88M -32.28M -34.44M
Total Depreciation and Amortization -- -- -- -- --
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 2.34M 2.16M 2.13M 2.23M 2.38M
Change in Net Operating Assets -7.44M -8.75M -6.65M -3.02M -97.00K
Cash from Operations -31.36M -33.71M -35.40M -33.07M -32.16M
Capital Expenditure -- -- -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- 0.00 -3.00M
Cash from Investing -- -- -- 0.00 -3.00M
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 47.57M 43.76M 46.82M 50.17M 30.53M
Repurchase of Common Stock -64.00K -64.00K -64.00K -31.00K -31.00K
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing 47.51M 43.69M 46.76M 50.14M 30.50M
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 16.15M 9.98M 11.36M 17.06M -4.66M